The Drosophila white gene is a member of the ATP-binding cassette (ABC) transporter superfamily and is involved in the cellular uptake of tryptophan. Its human homologue gene (hW) has been mapped to chromosome 21q22.3. Tryptophan is the precursor for the neurotransmitter serotonin, which has been implicated in the regulation of mood and anxiety. The locus 21q22.3 has also been reported to be associated with mood disorders. The 3Ј-untranslated region (3Ј-UTR) in the hW gene has been shown to contain a polymorphic poly(T) region. We have identified a new polymorphism G2457A in the 3Ј-UTR in the present study. We examined the relationship between these polymorphisms and mood and panic disorders, and a significant association between the poly(T) polymorphisms and mood disorders was detected (P = 0.039 (allele frequency)). Associations were found between the polymorphisms and mood (poly(T) polymorphism: P = 0.047 (allele frequency), G2457A: P = 0.040 (allele frequency), P = 0.044 (genotype frequency)) and panic disorders (G2457A: P = 0.026 (allele frequency), P = 0.011 (genotype frequency)) in males, but not in females. These findings suggest that the hW gene may be an important gene in the control of mood and anxiety as well as one of the genetic factors related to mood disorders and panic disorder in males. The statistical significance of the association remains relatively low and larger materials facilitating further dissection of the clinical phenotype will be needed to confirm and independently validate this finding and to evaluate its significance.
Introduction
Mood disorders are prevalent disorders that affect a small percentage of the general population. 1, 2 Family, twin, and adoption studies have supported the involvement of genetic factors in the pathogenesis of both bipolar and depressive disorders. 3 Several reports focused the putative loci for mood disorders on chromosome 4, 6, 13, 15, 18, 21, and X. 4 Straub et al 5 detected in a family with bipolar disorder and recurrent major depression a lod score of 3.41 at the PFKL locus on 21q22.3. Five additional families also showed a positive but modest lod score with PFKL. In addition, they obtained a statistically significant result (maximum P Ͻ 10 −6 ) in 47 families with bipolar disorder using the single locus (PFKL) and multilocus (PFKL/D21S171) affected-pedigree-member methods. Several groups [6] [7] [8] [9] have supported the above findings with expanded pedigrees. With sibpair analysis, sevCorrespondence: Dr A Sano, Department of Neuropsychiatry, Ehime University School of Medicine, Shitsukawa, Shigenobu, Onsen-gun, Ehime, Japan 791-0295. E-mail: sanoȰm.ehimeu.ac.jp Received 8 July 1998; revised and accepted 4 December 1998 eral markers on 21q22.3 also shared a high proportion of allele identity by descent. 7, 9 These findings strongly suggest that one of the susceptibility loci for mood disorders is on 21q22.3.
Family and twin studies have suggested etiological genetics in panic disorder, [10] [11] [12] [13] and are commonly found with high frequency in mood disorder pedigrees. 14 In addition, high frequency of comorbidity between mood disorders and panic disorder is well recognized. 15 The efficacy of selective serotonin reuptake inhibitors as well as traditional tricyclic antidepressants in both mood disorders and panic disorder has led to the serotonin hypothesis in the molecular pathogenesis of these disorders. Recently, an hW gene was isolated and identified within 2 cM of PFKL on 21q22.3. 16, 17 The gene is a member of the ABC transporter gene family; 18, 19 in Drosophila the white gene is involved in the cellular uptake of guanine and tryptophan. 20 Tryptophan is the precursor of the neurotransmitter, serotonin. Therefore, the hW gene may be a good candidate gene for the cause of mood and panic disorders. The hW gene shows a poly(T)-polymorphism in its 3Ј-UTR. 16 In the present paper, we report a novel polymorphism in the 3Ј-UTR, and the association between the polymorphisms and mood and panic disorders in males.
Materials and methods

Subjects
The patients were recruited from the general psychiatric clinics of Ehime University Hospital. Written informed consents were obtained from all patients. The clinical information was based on personal interviews and supplemented by medical records. Diagnoses were made using the diagnostic criteria according to DSM-IV, 21 using all available information and by consensus of at least two psychiatrists. Patients were diagnosed with mood disorders (n = 88, 54 male and 34 female, mean age 50.2 years) or panic disorder (n = 41, 21 male and 20 female, mean age 38.6 years). Control subjects who were psychiatrically healthy (n = 130, 59 male and 71 female, mean age 48.3 years) were also collected with written informed consents. Both patient and control subjects were unrelated native Japanese. Genomic DNA was prepared from peripheral blood lymphocyte according to the standard method.
Mutation screening and sequence analysis PCR amplification was performed for hW gene 3Ј-UTR using the primers HDW-U [5Ј-CGCGGAT CCTCCGCATTGCCTATT-3Ј (add a BamHI site GGATCC in 5Ј end)] and HDW-U [5Ј-CCGCTCGA GACGTGGAAAAAGAAAGACT-3Ј (add a XhoI site in 5Ј end)] in a total volume of 100 l containing 100 ng genomic DNA, 10 l of 10 × Expand HF Buffer (Boehringer Mannheim, Mannheim, Germany), 1.0 mM MgCl 2 , 150 M dNTPs, 0.8 M each primer and 5.25 U of Expand ™ High Fidelity PCR system enzyme mix (Boehringer Mannheim) for 10 cycles (94°C for 15 s, 52°C for 30 s, 68°C for 1 min) and 20 cycles (94°C for 15 s, 60°C for 20 s, 72°C for 1 min plus cycle elongation of 5 s for each cycle). Then the PCR products were digested using the restriction enzymes BamHI and XhoI (New England Biolab, MA, USA).
The products were electrophoresed on 1% agarose gel in 0.5 × TBE, stained with ethidium bromide and appropriate-sized bands were excised. The gel slices were purified using Gene clean kit II (Funakoshi, Tokyo, Japan). The products were subcloned into BamHI and XhoI site of plasmid vector pcDNA3 (Invitrogen, CA, USA), and sequenced using Bca BEST ™ Dideoxy Sequencing Kit (Takara, Tokyo, Japan).
Genotyping
PCR amplification was performed for polymorphic poly(T) in 3Ј-UTR of hW gene. The primers, Wpoly(t)F (5Ј-TCTCCATTCCCCTTTCTAGC-3Ј) and Wpoly(t)R (5Ј-TCTCATCACCAGCTGTGTTG-3Ј) previously described 17 were used for PCR amplification. PCR amplification was performed in a total volume 6.25 l containing 50 ng genomic DNA, 10 mM Tris-HCl (pH 8. for 20 s, 72°C for 20 s). PCR products were electrophoresed on 6% polyacrylamide/42% urea gel. For analysis of the polymorphism, G2457A, PCR-RFLP was performed using primers HDW-U and HDW-L in a total volume of 12.5 l containing 100 ng genomic DNA, 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 200 M dNTPs, 0.2 M each primer and 0.5 U of Taq polymerase (Takara) for 30 cycles (94°C for 30 s, 52°C for 30 s, 72°C for 1 min). Then PCR products were digested with 10 U of HhaI (New England Biolab). The digested products were analyzed in 1.5% agarose gel.
Statistical analysis
Statistical analysis consisted of chi-squared tests for Hardy-Weinberg equilibrium. The difference between groups of patients and controls with respect to allelic and genotypic frequencies was compared using exact test (two-tailed). Odds ratios with 95% confidence intervals were estimated for the effects of high risk genotypes and allele. The Armitage linearity tendency test 22 was used to identify any dose effect of a susceptibility allele. Probability values of 0.05 or less were regarded as statistically significant.
Results
Identification of a new polymorphism in the 3Ј-UTR and poly(T) polymorphism
We identified a A → G transversion at nucleotide position 2457 in a healthy control genomic clone when compared with the published sequence ( Figure 1 ). This A2457G substitution in 3Ј UTR creates a new HhaI restriction site (Figure 2 ). The genotypic distribution studied by PCR restriction fragment length polymorphism analysis (PCR-RFLP) in controls in the present study was in Hardy-Weinberg equilibrium (total controls: Three different alleles were observed in our Japanese subjects in the PCR analysis of the poly(T) region ((T) 13 to (T) 15 ). ((T) 13 allele has 13 t in poly(T) region beginning at nt 2288 (Figure 1 ), although a prior study reported five different alleles in Caucasian individuals ((T) 11 to (T) 15 ). 16 We found a linkage disequilibrium between the A2457G and poly(T) polymorphisms ( 2 = 277.3, P Ͻ 0.0001, d.f. = 2). Subjects whose genotypes were homozygous for the 2457A allele (A/A) had (T) 13 /(T) 13 , G/G had (T) 14 /(T) 14 , (T) 15 /(T) 15 , or (T) 14 /(T) 15 , and the subjects with G/A genotype had (T) 13 /(T) 14 or (T) 13 /(T) 15 . There was one exception: a patient subject (bipolar disorder, 69 years old, female) who had a G/G genotype with (T) 13 /(T) 15 .
A2457G polymorphism
The genotypic and allelic frequencies are shown in Table 1 . When each patient group in both sexes was compared with the control group, there were no sig- nificant differences between each patient group and controls. In males, the genotypic frequencies differed significantly between the patients with mood disorders (combined major depression and bipolar disorder) or panic disorder, and controls (P = 0.044, 0.011, respectively). In allelic frequency, significant increases in 2457-A allele prevalence were observed in all male patient groups with mood and panic disorders compared with the male controls (P = 0.040, 0.026, respectively). No significant difference was observed between any female patient groups and female controls (mood disorders: P = 0.88; panic disorder: P = 0.14).
Odds ratios (OR) of each disorder associated with the 2457-A allele are shown in Table 2 . Male patient groups showed higher scores than female or total groups in all disorders. The risks for male patient groups were significantly increased by the presence of at least one copy of the 2457-A allele. A strikingly high odds ratio of 7.00 for panic disorder was obtained for the males bearing 2457-A alleles heterozygously (P = 0.0042). In male groups, there was a significant dose effect for the risk associated with the 2457-A allele for mood disorders and panic disorder as assessed by the linearity tendency test (mood disorders: 2 = 6.32, P = 0.042, d.f. = 2; panic disorder: 2 = 9.07, P = 0.011, d.f. = 2, respectively). Table 3 shows genotypic and allelic frequencies. The control genotypic frequency in both sexes was in Hardy-Weinberg equilibrium ( 2 = 5.80, P = 0.12, d.f. = 3). The frequency of the (T) 13 allele was significantly higher in the patients with mood disorders compared with the controls (P = 0.040). In males, the frequency of the (T) 13 allele was significantly higher in the patients with mood disorders (P = 0.047). No significant difference between female patient groups and controls was found.
Poly(T) polymorphism
Discussion
Several parametric or nonparametric linkage studies strongly suggest that one of the susceptibility loci for mood disorders is on 21q22.3 [5] [6] [7] [8] [9] However, little is known about investigations of genetic association study in 21q22.3. The hW gene was recently isolated and identified within 2 cM of PFKL on 21q22.3.
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Because of its chromosomal location at 21q22.3, high 17 We report here significant positive associations of the polymorphisms in the 3Ј-UTR of the hW gene with both mood disorders and panic disorder. These associations were found not in females but in males. The odds ratios of the male bearers of at least one hW-2457-A allele were 2.69 and 6.21 for mood disorders and panic disorder, respectively. There was a significant dose effect of hW-2457-A allele on the risk for mood and panic disorders in males.
The white gene of Drosophila is a member of the ABC transporter superfamily and is involved in the cellular uptake of guanine and tryptophan. However, the function of hW is unknown. If hW is a determinant of tryptophan uptake, it may serve as an important modulator of the substrate for serotonin synthesis. The efficacy of selective serotonin reuptake inhibitors as well as traditional tricyclic antidepressants in both mood disorders and panic disorder has led to the serotonin hypothesis in the molecular pathogenesis of these disorders. Our results may prove to be reasonable evidence for the serotonin hypothesis of these disorders.
The existence of gender difference in the prevalence of both unipolar disorder and panic disorder has been well known as clinical fact. Both disorders occur in women about twice as frequently as in men. The reason for the molecular mechanism of sex difference in these diseases is unknown. However, it has been recently demonstrated using positron emission tomography that the rate of serotonin synthesis in the human brain in males is about 1.5 times higher than in females, 23 which may be related to gender difference in these diseases. Our present study showed that the hW gene polymorphism is associated only with male patients, which indicates that the hW gene may be one of the causes for gender differences in mood and anxiety disorders. There have been few discussions about sex difference of these diseases in any previous genetic linkage or association study. Our results lead to the suggestion that analysis of sex difference may be needed in further genetic linkage or association studies.
It is unclear how the 2457-A and poly(T) 13 alleles act as risk factors for mood disorders and panic disorder. It is of interest that there is also a poly(T) region found in the 3Ј-UTR of the Drosophila W gene 24, 25 and mouse ABC8. 26 The conservation of this poly(T) over evolution is remarkable and suggests perhaps the poly(T) region has a functional significance. A2457G polymorphism may also have a functional significance. These polymorphisms are located in a 3Ј-UTR and therefore might affect hW gene expression.
In conclusion, although the statistical significance of the association remains relatively low and larger materials facilitating further dissection of the clinical phenotype will be needed to prove the potentially interesting finding and to evaluate its significance for the disease, our results suggest that the hW gene may be an important gene in the control of mood and anxiety and may be one of the genetic factors to cause mood disorders and panic disorder in males.
